BDP 558/568 amine
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 174C0 | 1 mg | $125 | in stock | |
| 274C0 | 5 mg | $260 | in stock | |
| 474C0 | 25 mg |
$510
|
in stock | |
| 574C0 | 50 mg |
$895
|
in stock | |
| 674C0 | 100 mg |
$1490
|
in stock |
Primary amine is a versatile functional group for bioconjugation. It is reactive against activated carboxylic acid derivatives like pentafluorophenyl esters and acyl halogenides, other electrophiles like epoxides, Michael acceptors like acrylates. It can aminate carbonyl compounds like aldehydes and ketones in reductive conditions.
BDP 558/568 is a universal borondipyrromethene dye with the emission in orange/yellow part of the spectrum.
Absorption and emission spectra of BDP 558/568
Customers also purchased with this product
BDP TR X NHS ester
BDP TR X NHS ester is a derivative of BDP TR containing a long linker based on aminohexanoic acid (C6). The dye has absorption and emission close to ROX. The NHS ester function can be used to conjugate proteins and peptides.Cyanine3 NHS ester
Amine-reactive Cyanine3 dye NHS ester for the labeling of amino-groups.AF 430 amine
AF 430 dye with a terminal amino group with emission in the yellow-green region of the spectrum.General properties
| Appearance: | dark colored powder |
| Molecular weight: | 480.81 |
| Molecular formula: | C22H28N4BClF2OS |
| Solubility: | good in DMF, DMSO |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation/absorption maximum, nm: | 561 |
| ε, L⋅mol−1⋅cm−1: | 84400 |
| Emission maximum, nm: | 569 |
| Fluorescence quantum yield: | 0.68 |
| CF260: | 0.00 |
| CF280: | 0.07 |
Product citations
- Nabar, N.; Dacoba, T.G.; Covarrubias, G.; Romero-Cruz, D.; Hammond, P.T. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies. Proceedings of the National Academy of Sciences of the United States of America, 2024, 121(11), e2307809121. doi: 10.1073/pnas.2307809121
BDP® is a trademark of Lumiprobe
The count of items is incorrect.
Your cart is empty
$ 
